Follow
Peter Jarcuska
Peter Jarcuska
Associate professor, 1st Dept of Internal Medicine, UPJS LF Kosice, Slovakia
Verified email at upjs.sk - Homepage
Title
Cited by
Cited by
Year
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
S Blach, S Zeuzem, M Manns, I Altraif, AS Duberg, DH Muljono, I Waked, ...
The lancet Gastroenterology & hepatology 2 (3), 161-176, 2017
20752017
Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study
D Razavi-Shearer, I Gamkrelidze, MH Nguyen, DS Chen, P Van Damme, ...
The lancet Gastroenterology & hepatology 3 (6), 383-403, 2018
14912018
The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology
J Trebicka, J Fernandez, M Papp, P Caraceni, W Laleman, C Gambino, ...
Journal of hepatology 73 (4), 842-854, 2020
3372020
Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study
H Razavi, S Robbins, S Zeuzem, F Negro, M Buti, AS Duberg, ...
The lancet Gastroenterology & hepatology 2 (5), 325-336, 2017
3082017
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
S Blach, NA Terrault, F Tacke, I Gamkrelidze, A Craxi, J Tanaka, I Waked, ...
The Lancet Gastroenterology & Hepatology 7 (5), 396-415, 2022
3072022
The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm–volume 2
A Hatzakis, V Chulanov, AC Gadano, C Bergin, Z Ben‐Ari, J Mossong, ...
Journal of viral hepatitis 22, 26-45, 2015
247*2015
PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis
J Trebicka, J Fernandez, M Papp, P Caraceni, W Laleman, C Gambino, ...
Journal of hepatology 74 (5), 1097-1108, 2021
1872021
Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe
AD Marshall, EB Cunningham, S Nielsen, A Aghemo, H Alho, ...
The lancet Gastroenterology & hepatology 3 (2), 125-133, 2018
1652018
Historical epidemiology of hepatitis C virus (HCV) in select countries–volume 2
V Saraswat, S Norris, RJ De Knegt, JF Sanchez Avila, M Sonderup, ...
Journal of viral hepatitis 22, 6-25, 2015
1422015
Circulating markers of liver fibrosis progression
P Jarčuška, M Janičko, E Veselíny, P Jarčuška, Ľ Skladaný
Clinica Chimica Acta 411 (15-16), 1009-1017, 2010
1112010
Coenzyme Q10 and selenium in statin-associated myopathy treatment
J Fedacko, D Pella, P Fedackova, O Hänninen, P Tuomainen, P Jarcuska, ...
Canadian journal of physiology and pharmacology 91 (2), 165-170, 2013
1052013
Strategies to manage hepatitis C virus (HCV) infection disease burden–volume 2
E Gane, D Kershenobich, C Seguin‐Devaux, P Kristian, I Aho, O Dalgard, ...
Journal of viral hepatitis 22, 46-73, 2015
912015
Chronic hepatitis C association with diabetes mellitus and cardiovascular risk in the era of DAA therapy
S Drazilova, J Gazda, M Janicko, P Jarcuska
Canadian Journal of Gastroenterology and Hepatology 2018, 2018
752018
Are barriers in accessing health services in the Roma population associated with worse health status among Roma?
P Jarcuska, D Bobakova, J Uhrin, L Bobak, I Babinska, P Kolarcik, ...
International journal of public health 58, 427-434, 2013
752013
Serum cholesterol is a significant and independent mortality predictor in liver cirrhosis patients
M Janičko, E Veselíny, D Leško, P Jarčuška
Annals of hepatology 12 (4), 413-419, 2013
572013
Is the cardiovascular risk profile of people living in Roma settlements worse in comparison with the majority population in Slovakia?
I Babinska, ZD Veselska, D Bobakova, D Pella, S Panico, SA Reijneveld, ...
International journal of public health 58, 417-425, 2013
562013
Pleiotropic effects of statins in the diseases of the liver
M Janicko, S Drazilova, D Pella, J Fedacko, P Jarcuska
World Journal of Gastroenterology 22 (27), 6201, 2016
552016
Association between hepatitis B and metabolic syndrome: Current state of the art
P Jarcuska, S Drazilova, J Fedacko, D Pella, M Janicko
World journal of gastroenterology 22 (1), 155, 2016
542016
Does the population living in Roma settlements differ in physical activity, smoking and alcohol consumption from the majority population in Slovakia
I Babinská, AM Gecková, P Jarcuska, D Pella, M Mareková, G Stefkova, ...
Cent Eur J Public Health 22 (Supp. l), P22-7, 2014
542014
Hepatitis B virus infection in patients with metabolic syndrome: a complicated relationship. Results of a population based study
P Jarčuška, M Janičko, P Kružliak, M Novák, E Veselíny, J Fedačko, ...
European journal of internal medicine 25 (3), 286-291, 2014
502014
The system can't perform the operation now. Try again later.
Articles 1–20